Investments Laidlaw maintains Buy rating on IN8bio, target at $7.50 By Investing.com – Investing.com Last updated: 2024/06/15 at 11:59 PM By Editor 0 Min Read Share SHARE Laidlaw maintains Buy rating on IN8bio, target at $7.50 By Investing.com Investing.comsource You Might Also Like Amazon hits $2 trillion in valuation on AI fervor, rate cut bets By Reuters – Investing.com Midday movers: FedEx, Rivian, Whirlpool rise; Paychex falls By Investing.com – Investing.com Investment outlook for global equities in 2H 2024 – Barclays By Investing.com – Investing.com This stock is seen as Nvidia's 'little brother' By Investing.com – Investing.com Citi: Rumors of software's AI death are greatly exaggerated By Investing.com – Investing.com TAGGED: Articles Editor June 15, 2024 June 15, 2024 Share This Article Facebook Twitter Email Print Previous Article Barclays maintains equal weight on American Express, target $221 By Investing.com – Investing.com Next Article Audrina Miranda Joins New ‘Jurassic World’ Movie – Hollywood Reporter Leave a comment Leave a Reply Cancel reply Connect with: Your email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Stay Connected Facebook Like Twitter Follow Youtube Subscribe Telegram Follow - Advertisement - Latest News Amazon hits $2 trillion in valuation on AI fervor, rate cut bets By Reuters – Investing.com Investments Midday movers: FedEx, Rivian, Whirlpool rise; Paychex falls By Investing.com – Investing.com Investments Investment outlook for global equities in 2H 2024 – Barclays By Investing.com – Investing.com Investments This stock is seen as Nvidia's 'little brother' By Investing.com – Investing.com Investments